Allison Naumovski

2PUBLICATIONS
5CO-AUTHORS
AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 14, 2024
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab.

Ludimila Cavalcante, Sreenivasa Chandana, Nehal Lakhani

|Aug 03, 2024
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2).

Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani

Pageof 1

Frequent Collaborators

2 joint publications

Diwakar Davar

2 joint publications

Nehal Lakhani

1 joint publications

Justin Moser

1 joint publications

Rachel E Sanborn